Literature DB >> 30916727

Pathway-specific light adaptation in human electroretinograms.

Alódia Brasil1,2, Tina I Tsai2, Givago da Silva Souza1,3, Anderson Manoel Herculano1, Dora Fix Ventura4, Luiz Carlos de Lima Silveira1,3,5, Jan Kremers2.   

Abstract

The cellular origins of slow ERG changes during light adaptation following a dark-adapted state are still unclear. To study light adaptation, six healthy, normal trichromats were dark-adapted for 30 min prior to full-field ERG recordings to sinusoidal stimuli that isolate responses of the L- or M-cones or that stimulate luminance and chromatic mechanisms at 12 or 36 Hz. Recordings were performed for 16 min with 2-min intervals after onset of a constant background. Generally, the responses were sine-wave-like, and the first harmonic (fundamental) component dominated the Fourier spectrum except for the 12-Hz luminance stimulus in which two components, a sine-wave-like component and a transient component, determined the response profiles, leading to large second harmonic components. The amplitude of the first harmonic component (F) increased as a function of the light-adaptation time except for the 12-Hz luminance stimulus at which the F component decreased as a function of the light-adaptation period. The phase of the first harmonic component changed only slightly (less than 30°) during the light-adaptation period for all stimuli conditions. The L/M ratio in luminance reflecting ERGs decreased with increasing adaptation time. Our present data suggest that the light-adaptation process mainly reflects changes in the luminance pathway. The responses to 12-Hz luminance stimuli are determined by two different luminance driven pathways with different adaptation characteristics.

Entities:  

Mesh:

Year:  2019        PMID: 30916727     DOI: 10.1167/19.3.12

Source DB:  PubMed          Journal:  J Vis        ISSN: 1534-7362            Impact factor:   2.240


  1 in total

1.  Pseudorandom full-field electroretinograms reflect different light adaptation mechanisms.

Authors:  Juliana Bizerra Assis; Alódia Brasil; Terezinha Medeiros Gonçalves Loureiro; Veronica Gabriela Ribeiro da Silva; Anderson Manoel Herculano; Dora Fix Ventura; Luiz Carlos Lima Silveira; Jan Kremers; Givago Silva Souza
Journal:  Doc Ophthalmol       Date:  2021-02-19       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.